Main characteristics of the all-male control population
| Control . | Age, y . | CD4+ cells/mm3 . | HIV-RNA log copies/mL . | Antiretroviral therapy . |
|---|---|---|---|---|
| 1 | 46 | 814 | < 2.3 | Triple |
| 2 | 55 | 145 | 4.37 | Triple |
| 3 | 35 | 605 | < 2.3 | Triple |
| 4 | 39 | 514 | < 2.3 | Triple |
| 5 | 32 | 568 | < 2.3 | Triple |
| 6 | 37 | 859 | < 2.3 | Triple |
| 7 | 61 | 291 | 2.48 | Triple |
| 8 | 34 | 760 | < 2.3 | Triple |
| 9 | 38 | 624 | < 2.3 | Triple |
| 10 | 33 | 699 | < 2.3 | Triple |
| 11 | 49 | 304 | 5.11 | Triple |
| 12 | 43 | 310 | 3.89 | No |
| Control . | Age, y . | CD4+ cells/mm3 . | HIV-RNA log copies/mL . | Antiretroviral therapy . |
|---|---|---|---|---|
| 1 | 46 | 814 | < 2.3 | Triple |
| 2 | 55 | 145 | 4.37 | Triple |
| 3 | 35 | 605 | < 2.3 | Triple |
| 4 | 39 | 514 | < 2.3 | Triple |
| 5 | 32 | 568 | < 2.3 | Triple |
| 6 | 37 | 859 | < 2.3 | Triple |
| 7 | 61 | 291 | 2.48 | Triple |
| 8 | 34 | 760 | < 2.3 | Triple |
| 9 | 38 | 624 | < 2.3 | Triple |
| 10 | 33 | 699 | < 2.3 | Triple |
| 11 | 49 | 304 | 5.11 | Triple |
| 12 | 43 | 310 | 3.89 | No |
HIV indicates human immunodeficiency virus.